Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

More convenient formulation of Azmacort cleared for asthma prophylaxis

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

NDA submitted for breakthrough pain Rx

Nov. 15, 1996

American Biogenetic Sciences' blood clot diagnostic test cleared for marketing

Nov. 8, 1996

FDA advisory committee deems ACEL-IMUNE safe and effective for use in infants

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...